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Photodynamic therapy is currently being evaluated as a
minimally invasive procedure for endometrial ablation not
requiring anaesthesia. Light penetration depths at 630, 660
and 690 nm and the optimal configuration of intrauterine
light-diffusing fibres were determined in 14 human uteri
to assist in the design of a light intrauterine device. Post-
menopausal ex-vivo uteri showed a significantly lower light
penetration depth than pre-menopausal uteri. With a single
central diffusing fibre inserted, the fluence rate measured
in the uterine wall at the most remote point of the cavity
decreased to 1.1 ± 0.4% of that measured at closest
proximity, whereas it decreased to only 40.0 ± 9.0% with
three fibres. Distension of the uterine cavity with 2 ml of
an optically clear fluid increased the fluence rate at the
fundus between the fibres at a depth of 2 mm by a factor
of 4. We conclude that in normal-sized pre-menopausal
uterine cavities, three diffusing fibres will deliver an optical
dose above the photodynamic threshold level at a depth of
4 mm, even in the most remote areas, in <30 min without
causing thermal damage. For distorted and elongated
cavities, either slight distension of the cavity or the insertion
of a fourth diffusing fibre is required.
Key words: endometrium/intrauterine light delivery/light
dosimetry/photodynamic therapy
Introduction
Photodynamic therapy (PDT) is an experimental medical
treatment which requires specific interactions between light
and a photosensitizer to induce oxidation reactions and cause
tissue necrosis. Several animal studies (Schneider et ai, 1988;
Manyak et ai, 1989; Bhatta et ai, 1992; Yang et ai, 1993;
Wyss et ai, 1994a,b; Steiner et ai, 1995) have shown that the
selective destruction of the endometrium using PDT is feasible
and may provide a viable alternative to routinely performed
surgical treatments which require anaesthesia and imply
specific risks and complications (Goldrath et ai, 1981; De
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Cherney and Polan, 1983; Jedeikin et ai, 1990; Perry and
Baughman, 1990; Brooks et ai, 1991; Serden and Brooks,
1991; Daniell et ai, 1992). PDT may, therefore, offer a simple,
cost-effective and safe alternative to more radical surgical
procedures for the treatment of dysfunctional uterine bleeding.
Systemic and topical applications of various photosensitizers
have been studied. Intrauterine administration offers potential
advantages, including the lack of skin photosensitivity. Several
studies have suggested that the endometrial surface regenerates
from the residual epithelium of the gland stumps where stem
cells are most likely to be present (Ferenczy, 1976). In
humans, the glandular crypts of the basal endometrial layer,
the regeneration site for new endometrial cells, lie within the
innermost myometrial layer. Accordingly, a sufficient optical
dose must be delivered to the entire endometrium, including
the innermost myometrial layer, to induce irreversible photo-
chemical destruction. The thickness of the normal endometrium
varies between 1 and 5 mm, depending on the phase in the
menstrual cycle (Santolaya-Forgas, 1992).
The aim of this study was to determine the light distribution
inside the uterine wall using between one and three intrauterine
light-diffusing fibres in intact uteri immediately following
hysterectomy. Given this information, light exposure times
necessary for the photodynamic destruction of the entire
endometrium can be calculated for different configurations of
intrauterine light delivery devices.
Materials and methods
A total of 10 pre-menopausal [age (mean ± SE) 40.3 ± 1.0 years]
and four post-menopausal (age 57.8 ± 3.0 years) patients scheduled
for hysterectomy for benign conditions, such as leiomyoma and
uterine prolapse, participated in this study. The intact fresh uterine
specimens were obtained immediately after hysterectomy and put on
ice. The uterine vessels were clamped proximal and distal to the
dissection site to keep the blood in the tissue. During the measurement
period (2-4 h), wet gauze was applied to the specimen to prevent
dehydration.
The clinical histories and pathology reports were reviewed to
obtain the following information: patient age, menopausal status, day
of menstrual cycle at surgery, hormonal treatment during the last 3
months and histopathological findings. The study was approved by
the Human Subject Review Committee of the University of California,
Irvine, CA, USA.
The light source was an argon-ion laser (Innova 90-5; Coherent,
Palo Alto, CA, USA) used to pump a dye laser (Coherent Model
599) containing DCM dye (Exciton Inc., Dayton, OH, USA). The
laser beam was coupled into flexible quartz fibres with cylindrical
diffusing tips of 3 cm length and 1.2 mm diameter (Model 4420-
A02; PDT Systems Inc., Santa Barbara, CA, USA) via a three-way
fibre splitter (PDT Systems). One, two or three fibres were inserted
3067
M.K.Fehr et al.
into the uterine cavity through the cervical canal under hysteroscopic
guidance. Two fibres were placed at the lateral edges of the uterine
cavity with the fibre tips located at the entrance to the corresponding
Fallopian tube. The third fibre was positioned in the middle of the
uterine cavity with the tip touching the fundus. The fibres were held
in place by a single 6-0 monofilament polypropylene suture attached
to the tip of the diffusing fibre and pulled through the uterine wall.
To collect light with equal efficiency from all directions, a 200 \).m
core diameter detection fibre with a spherical isotropic collection tip
(diameter = 0.8 mm; PDT Systems) was used. The detection
fibre was connected to a photomultiplier tube (Hamamatsu R 928;
Bridgewater, NJ, USA) to measure the steady-state light intensity
(ftuence rate). The detector probe was calibrated in water using a 7.2
mW (k = 633 nm) He-Ne laser. The optical powers emitted from
each of the cylindrical fibres were evaluated by inserting them into
an integrating sphere and comparing the signals with those obtained
from the He-Ne laser.
The detection fibre was inserted into an 18 G needle which
perforated the uterine wall in a direction normal to the uterine surface
and the cylindrical diffusing fibres. The needle was removed and the
detector fibre retracted under hysteroscopic visualization until the
spherical probe entered the endometrium. The hysteroscope was then
removed and the CO2 gas was evacuated to allow the cavity to
collapse. The detection fibre was then retracted into the tissue using
a micropositioner, and steady-state measurements of light intensity
were recorded as a function of separation from the uterine cavity.
The optical penetration depth is defined as the distance from the
surface of the tissue at which the fluence rate drops to 37% of its
initial value (Wyss et al., 1995). The calculation of the penetration
depth from the measured fluence rates at different source detector
separations has been described elsewhere (Svaasand, 1984; Tromberg
et al., 1995). If fibroids were visible macroscopically, the measure-
ments were made in tissue which appeared to be normal.
To determine light distribution, measurements were made at the
corners of the uterine cavity when only one central fibre was inserted,
between the source fibres when three fibres were inserted, and at the
centre of the fundus and corpus when only two lateral source fibres
were in place. Measurements were recorded at 630, 660 and 690 nm
wavelengths. The optical power of each fibre was kept constant
regardless of the number of fibres illuminated. To determine the effect
of uterine distension on the fluence rate at distances of 2 and 6 mm
from the endometrial surface, 9 ml of a high viscosity, optically clear
liquid (Hyskon®; Pharmacia Inc., Piscataway, NJ, USA) were injected
into the uterine cavity. To avoid spillage, the isthmic portion of the
Fallopian tubes was clamped, and the Hyskon was injected through
a Bard Cervical Cannula® (C.R.Bard Inc., Billerica, MA, USA), with
an inflated balloon in place to block the cervical canal.
After making these measurements, the uteri were opened by a
Y-shaped incision of the anterior wall, and the dimensions of the
uterine cavity were measured. The unpaired, two-tailed /-test was
used for a statistical comparison of light penetration depth between
pre- and post-menopausal women. For the comparison of penetration
depths at different wavelengths, the paired, two-tailed r-test was used.
Statistical significance was taken as P < 0.05. Data are presented as
mean ± SE.
Results
The pre-menopausal uteri weighed 498 ± 188 g, with a
transverse diameter of the uterine cavity of between 30 and
95 mm (48 ± 12). The post-menopausal uteri weighed 71 ±
21 g, with a transverse diameter of the uterine cavity ranging
from 28 to 56 mm (40 ± 6). Histology revealed that six of
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Figure 1. Decay of fluence rate by retracting the detector probe
from the endometrial surface into the uterine wall of three pre-
menopausal women. The power of the cylindrical light-diffusing
fibre is 100 mW per cm of fibre length. The curve represents the
calculated values after an equation given by Svaasand (1984) and
Tromberg et al. (1995).
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Figure 2. Penetration depth of light into the uterine tissue at
different wavelengths and percentage increase of fluence rate at a
depth of 4 mm compared with the fluence rate measured at 630 nm
light. A total of 10 pre-menopausal and four post-menopausal
patients were studied. The light source lies in the uterine cavity and
the detector probe is retracted from the endometrial surface into the
uterine wall. Histogram bars represent mean ± SE. At 630 nm,
light penetration into post-menopausal uteri is significantly lower
than into pre-menopausal (P = 0.004, unpaired r-test). In pre- and
post-menopausal women, light penetration increases significantly
with increasing wavelength from 630 to 690 nm (P = 0.02 and
P = 0.04, paired r-test).
the pre-menopausal patients had secretory phase endometrium
and four had proliferative endometrium. Of the post-
menopausal uteri, two displayed proliferative and two inactive
endometrium.
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Figure 3. Percentage of fluence rate measured at different sites in
the uterine cavity compared with fluence rate in closest proximity
to light-diffusing fibre at a depth of 2 mm (wavelength 630 nm).
Longitudinal and transverse sections of the uteri are shown with the
endometrium embedding the light source fibres. (A) With a single
diffusing fibre as the light source. (B) With two and (C) with three
inserted light-diffusing fibres. Numbers represent mean ± SE.
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Figure 4. Increase of fluence rate at depths of 2 and 6 mm from
the endometrial surface during uterine distension by the instillation
of Hyskon into the cavities of four uteri. The isthmic portions of
the Fallopian tubes and cervical canals are blocked. Points
represent mean ± SE.
mm to 1.08 ± 0.4% of the fluence rate measured at the same
depth directly above the light source (Figure 3A). When two
lateral light sources were inserted, the fluence rate at the
middle of the fundus and the centre of the cavity decreased to
17.5 ± 3.0 and 59.5 ± 5.0% respectively (Figure 3B). In
Figure 3C, measurements were made between three illuminated
fibres at the fundus, and the fluence rate dropped to 40.0 ±
9.0%. In general, the distance between source fibres increased
with cavity size, resulting in a more pronounced drop in
fluence rate between the fibres (data not shown).
Distension of the uterine cavity produces an optically
integrating cavity which results in a more uniform light
distribution. Figure 4 shows that at depths of 2 and 6 mm, the
fluence rate between two diffusing fibres at the fundus increased
after distension with 2 ml of fluid by factors of 4.0 and 5.5
respectively. Following further dilation of the uterine cavity
using an additional 3 ml of Hyskon, the fluence rate increased
by factors of 8.0 and 13.5.
Figure 1 shows the approximately exponential decay of the
fluence rate of light in uterine tissue with increasing source-
detector separation in three examples. A comprehensive mathe-
matical model describing the decay in fluence rate with
increasing source-detector separation shown by the curve in
Figure 1 has been described by Svaasand (1984).
The penetration depth of light into the uterine tissue increased
with increasing wavelength (Figure 2). The increase from 630
to 690 nm was statistically significant for both pre- (P = 0.02)
and post-menopausal uteri (P = 0.04). The higher penetration
depth resulted in an increase in fluence rate at a depth of 4
mm of 58.0 ± 11.0% for pre-menopausal and 71.0 ± 23.0%
for post-menopausal uteri. Post-menopausal uteri showed a
statistically significant lower light penetration depth at 630 nm
than pre-menopausal samples (2.5 ± 0.3 versus 3.5 ± 0.1
mm; P = 0.004).
With a central fibre as the sole light source, the fluence rate
at the corners of the uterine cavity dropped at a depth of 2
Discussion
PDT is currently being evaluated as a minimally invasive
procedure for endometrial ablation, which may not require
anaesthesia and therefore could be performed in an office
setting (Wyss et al., 1995). Once a photosensitizer has accumu-
lated in the target tissue, the delivery of a sufficient optical
dose throughout the entire endometrium is necessary to induce
irreversible destruction. However, optical irradiation will initi-
ate a temperature rise in the tissue. To minimize the thermal
effects of irradiation, the power coupled into a cylindrical
light applicator should not exceed 100 mW/cm fibre length
(Svaasand, 1984; Tromberg et al., 1995). On the other hand,
to be clinically acceptable, treatment times should be kept
short, e.g. not longer than 30 min. Two strategies can be used
to minimize the time required to achieve a sufficient optical
dose at the endometrial-myometrial interface: (i) a photosensit-
izer with an excitation peak at a long wavelength can be
chosen, and (ii) the uterine cavity can be distended to achieve
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Table I. Calculated exposure times required to apply an optical dose of 70 J/cm2 at a depth of 4 mm at the most remote point from the source fibre for
differently sized uterine cavities
No. of fibres Fundus diameter Exposure time (min)
(mm)
630 nm 660 nm 690 nm
3
3
2
2
1
28
36
28
36
28
Pre-menopausal
8 = 3.6 mm
32
51
190
440
1600
Post-menopausal
8 = 2.5 mm
93
180
1100
3400
16 000
Pre-menopausal
8 = 4.3 mm
20
31
97
200
670
Post-menopausal
8 = 3.2 mm
44
75
320
81
3300
Pre-menopausal
8 = 4.7 mm
17
25
72
140
450
Post-menopausal
8 = 4.0 mm
24
37
120
260
920
Optical power = 100 mW per cm length of 0.8 mm diameter diffusing fibre. Times are given for pre-menopausal and post-menopausal samples using 630,
660 and 690 nm light. Penetration depths (8) vary with wavelength and physiological status, as shown. Reduced scattering coefficients are assumed to be 0.8
mm"1 for all cases. Exposure time calculations are based on a uterine light propagation model (Tromberg et al., 1995) and measured penetration depths.
Table II. Calculated exposure times required to apply an
J/cm2 at a depth of 4 mm at the most remote point from
differently sized uterine cavities
Diameter at fundus
(mm)
28
36
Exposure time (min)
Three fibres, no
distension
11.3
12.5
optical dose of 70
the source fibre for
Three fibres, 2 ml
distension
2.5
2.8
Exposure time calculations are based on absolute fluence rate measurements
in collapsed and distended uteri in the region of interest. Optical power =
100 mW per cm length of 1.2 mm diameter diffusing fibre for 660 nm light.
a more uniform light distribution. Light of a longer wavelength
will penetrate more deeply into tissue. At a given depth, a
higher optical dose will therefore be delivered for equal light
exposure times.
Here, we measured the penetration depths at 630, 660 and
690 nm because these are the excitation wavelengths used for
the photosensitizers 5-aminolevulinic acid-induced proto-
porphyrin IX (Goff et al, 1992), tin-etiopurpurin (Morgan
and Tertel, 1986) and benzoporphyrin monoacid ring A (Richter
et al., 1990). Our results show that by increasing the wavelength
from 630 to 690 nm, the penetration depth increases signific-
antly in both pre- and post-menopausal uteri. As shown in
Figure 2, this corresponds to an average increase in fluence
rate at 4 mm of 58% for pre-menopausal and 71 % for post-
menopausal uteri. Provided that photobiological effects are
comparable, exposure times can be reduced proportionally by
selecting a photosensitizer that is activated by the 690 nm
irradiation wavelength. The fact that optical penetration depths
in post-menopausal uteri are lower at all three wavelengths
can be explained by either a higher light absorption or an
increased scattering of post-menopausal uterine tissue. Indeed,
in post-menopausal uteri, both higher absorption and scattering
coefficients have been measured and attributed to post-
menopausal changes in water content, cell density and haemo-
globin absorption (Madsen et al., 1994).
To improve the uniformity of light distribution, the distension
of the organ by fluid instillation has been used in intracavitary
PDT of the bladder (Marynissen et al, 1989). Because acute
distension of the uterine cavity induces contractions and pain,
the insertion of multiple, thin, cylindrical diffusing fibres to
improve light uniformity seems to be a viable alternative. As
with the insertion of an intrauterine contraceptive device, this
could be carried without excessive discomfort or pain and
therefore without anaesthesia. Because the uterine cavity is
normally collapsed, an intrauterine light-diffusing fibre will be
surrounded by endometrial tissue and the light intensity will
rapidly decrease with increasing distance in all directions.
According to theory, the fluence rate will drop to -2% of the
initial value at a distance of four times the tissue-specific
penetration depth. This relationship was confirmed during
measurement at the corners of the uterine cavity (one source
fibre) when the fluence rate fell to <2% of initial values at a
source-detector separation of just over 14 mm (about four
times the penetration depth).
With multiple fibres inserted, the most critical region for
obtaining an adequate fluence rate is where the distance from
the source fibres is maximal, i.e. between the fibre tips in the
fundus. Calculated light exposure times for the photodynamic
destruction of the entire endometrium are shown for various
wavelengths and uterine optical properties in Table I. Details
of the uterine light dosimetry model are presented elsewhere
(Tromberg et al., 1995). These results are based on the
assumption that an optical dose of 70 J/cm2 is required at a
depth of 4 mm to destroy the endometrial gland stumps at the
endometrial-myometrial interface. Because measurements of
protoporphyrin IX photodegradation indicate that the proto-
porphyrin IX bleaching fluence is in the range 30-50 J/cm2
(Hoeydalsvik, 1994), an optical dose far above this value will
only lead to the destruction of the photosensitizer without an
additional photodynamic effect.
The uniformity of light distribution can be improved mark-
edly by separating the uterine walls. Under these conditions,
the uterine cavity acts as an 'integrating sphere' by reflecting
light at the endometrial surface (Tromberg et al., 1995; Wyss
et al, 1995). This can be achieved by filling the uterine cavity
with fluid. However, limitations include spillage through the
Fallopian tubes and pain/contractions which may occur with
large-volume injections. In practical terms, disadvantages to
fluid instillation can be minimized by using a small volume
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of viscous material, because even moderate distension of the
cavity can significantly reduce the required exposure time.
These concepts are illustrated in Figure 4, which shows that
the instillation of only 2 ml of a viscous, optically lossless
liquid such as Hyskon can increase the fluence rate (at 6 mm)
by a factor of -5 . Thus, from Table I, the required exposure
time for 630 nm radiation with three fibres in a distended
uterus could be reduced to 10 and 30 min for pre- and post-
menopausal patients respectively.
Despite this enhancement, the exposure time required using
a single source fibre is clearly unacceptable, even for small,
distended uterine cavities. Because choosing a longer wave-
length (690 nm) can only reduce the single-fibre exposure
time to, at best, 7.5 h, multiple source fibres are clearly
required for complete tissue destruction. However, even two
fibres are inadequate in a collapsed uterus, and distension may
be necessary for delivering the required light dose in a
reasonable time period, provided that optical penetration depths
are relatively high (e.g. -4 mm).
The delivery of an in-situ optical dose of 70 J/cm2 during
20 min of exposure at 100 mW/cm thus requires that the
maximum distance from the nearest fibre is in the range of
twice the optical penetration depth. An order-of-magnitude
estimate of the required exposure time in the case of a distance
between fibres equal to n times the penetration depth is: time
(min) = 20Xe(" ~ 2). For example, when n is equal to twice
the optical penetration depth, only 20 min are required;
however, doubling the distance between fibres so they are
separated by four penetration depths (n = 4) demands nearly
an 8-fold increase in exposure time (-150 min) to maintain
an equivalent optical dose.
Actual treatment times needed for irreversible endometrial
destruction may be different from those shown in Table I. These
estimates were determined by measuring ex-vivo penetration
depths, assuming a fixed scattering parameter, and calculating
the uterine light distribution using a dosimetry model for three
cylindrical fibres (Tromberg et ai, 1995). Because the model
assumes homogeneous optical properties, several 'real-world'
variations could contribute to errors in our calculations. These
may include non-uniform tissue structure and, despite our
attempts to retain blood in the specimen, differences in
optical properties between intact and surgically removed uteri.
Consequently, model calculations should be confirmed with
in-vivo measurements. To test our Table I predictions, we
recorded absolute fluence rates at the most remote locations
from three cylindrical fibres inserted into 24 and 36 mm
diameter uterine cavities (at depths of ~4 mm; however, since
the detector fibre was buried in tissue, its exact location could
only be estimated). Each cylinder received 100 mW per cm
of 660 nm light. Table II shows the exposure times required
to apply an optical dose of 70 J/cm2 based on: exposure time =
optical dose (70 J/cm2)/measured fluence rate (mW/cm2). Uteri
were probed in both collapsed and distended (2 ml) states.
Without distension, measurements indicate that the desired
light dose obtained from fluence rate measurements agrees
with model predictions within a factor of -2.0. Given that the
detector fibre position and uterine tissue optical properties
(Penetration depth 8 is assumed to be 4.3 mm at 660 nm)
were not determined accurately, we believe that this is an
encouraging result. The addition of 2 ml of Hyskon to distend
the uterus increased the measured fluence rate by a factor of
-4.5, resulting in concomitant reductions in required exposure
times. Overall, these measurements provide further confirma-
tion of the accuracy of our predictive light dosimetry model
and suggest that Table I results may be conservative 'worst
case' estimates. Deviations between measured (Table II) and
predicted (Table I) data are probably a result of experimental
uncertainties as well as tissue structural inhomogeneities.
In conclusion, our results suggest that a sufficient optical
dose for photodynamic destruction of the entire endometrium
without a risk of thermal effects by high optical powers can
reasonably be achieved using multiple diffusing fibres. In
normal-sized pre-menopausal uterine cavities (28 mm fundus),
a trifurcated intrauterine light delivery device will deliver an
optical dose of 70 J/cm2 (630 nm) at a depth of 4 mm, even
to the most remote areas, in -30 min (Table I). However,
when the uterine cavity is distorted and elongated by fibroids,
slight distension of the cavity may be required to provide a
sufficient optical dose throughout the endometrium. These
results have encouraged us and others, and suggest that
endometrial PDT may ultimately provide several benefits
compared with conventional surgical techniques. Among these
advantages is the possibility that endometrial PDT will not
require anaesthesia and operating room facilities. Thus,
although it is difficult to predict cost, this improvement alone
would make endometrial PDT a more economical alternative
to existing surgical procedures. In addition, with the increased
availability of inexpensive optical components, such as com-
pact, efficient diode lasers, flexible light diffusers and novel
photosensitizers, we expect that a variety of technological
developments will have a positive impact on its availability.
Acknowledgements
We thank M.Shell, PhD, for help in statistical analyses. M.K.F. wishes
to acknowledge fellowship assistance from the Swiss National Science
Foundation. This work was supported by the National Institutes of
Health (NIH grant nos. R29GM50958 and R01CA32248) and the
Whitaker Foundation (WF16493). In addition, Beckman Laser Insti-
tute programmatic support was provided by the National Institutes of
Health (NIH grant no. 5P41RR01192-15), the Department of Energy
(DOE grant no. DE-FG03-91ER61227) and the Office of Naval
Research (ONR grant no. N00014-91-C-0134).
References
Bhatta, N., Anderson, R.R., Flotte, T., Schiff, I., Hasan, T. and Nishioka, N.S.
(1992) Endometrial ablation by means of photodynamic therapy with
photofrin II. Am. J. Obslel. Gynecol., 167, 1856-1863.
Brooks, P.G., Serden, S.P. and Davos, I. (1991) Hormonal inhibition of the
endometrium for resectoscopic endometrial ablation. Am. J. Obstel.
Gynecol., 164, 1601-1606.
Daniell, J.F., Kurtz, B.R. and Ke, R.W. (1992) Hysteroscopic endometrial
ablation using the rollerball electrode. Obstel. Gynecol., 80, 329-332.
De Cherney, A. and Polan, M.L. (1983) Hysteroscopic resection of intrauterine
lesions and intractable uterine bleeding. Obstet. Gynecol., 61, 392-397.
Ferenczy, A. (1976) Studies on the cytodynamics of human endometrial
regeneration. I. Scanning electron microscopy. Am. J. Obstet. Gynecol.,
124, 64-74.
Goff, B.A., Bachor, R., Kollias, N. and Hasan, T. (1992) Effects of
photodynamic therapy with topical application of 5-aminolevulinic acid on
3071
M.K.Fehr et at.
normal skin of hairless guinea pigs. J. Pholochem. Pholobiol. B: BioL, 15,
239-251.
Goldrath, M.H., Fuller, T.A. and Segal, S. (1981) Laser photovaporization of
endometrium for treatment of menorrhagia. Am. J. Obstet. Gynecoi, 140,
14-19.
Hoeydalsvik, E. (1994) Characterization of the distribution of porphyrins in
malignant tumors by fluorescence. MSc Thesis, Division of Physical
Electronics, Norwegian Institute of Technology, Trondheim, Norway.
Jedeikin, R., Olsfanger, D. and Kessler, I. (1990) Disseminated intravascular
coagulopathy and adult respiratory distress syndrome: life-threatening
complications of hysteroscopy. Am. J. Obstet. Gynecoi, 162, 44-45.
Madsen, S.J., Wyss, P., Svaasand, L.O., Haskell, R.C., Tadir, Y. and Tromberg,
B.J. (1994) Determination of the optical properties of the human uterus
using frequency-domain photon migration and steady-state techniques. Phys.
Med. Biol., 39, 1191-1202.
Manyak, M.J., Nelson, L.M. and Solomon, D. (1989) Photodynamic therapy
of rabbit endometrium transplants: a model for treatment of endometriosis.
Fertil. Steril., 52, 140-145.
Marynissen, J.P., Jansen, H. and Star, W.M. (1989) Treatment system for
whole bladder wall photodynamic therapy with in vivo monitoring and
control of light dose rate and dose. J. Vrol, 142, 1351-1355.
Morgan, A.R. and Tertel, N.C. (1986) Observations on the synthesis and
spectroscopic characteristics of purpurins. J. Org. Chem., 51, 1347.
Perry, P.M. and Baughman, V.L. (1990) A complication of hysteroscopy: air
embolism. Anesthesiology, 73, 546-547.
Richter, A.M., Waterfield, E., Jain, A.K., Ethan, D., Sternberg, E.D.,
Dolphin, D. and Levy, J.G. (1990) In vitro evaluation of phototoxic
properties of four structurally related Benzoporphyrin derivatives.
Photochem. Photobiol., 52, 495-500.
Santolaya-Forgas, J. (1992) Physiology of the menstrual cycle by
ultrasonography. J. Ultrasound Med., 11, 139-142.
Schneider, D.F., Schellhas, H.F., Wesseler, T.A. and Moulton, B.C. (1988)
Endometrial ablation by DHE photoradiation therapy in estrogen-treated
ovariectomized rat. Colposc. Gynecoi. Laser Surg., 4, 73-77.
Serden, S.P. and Brooks, P.G. (1991) Treatment of abnormal uterine bleeding
with the gynecologic resectoscope. J. Reprod. Med., 36, 697-699.
Steiner, R.A., Tromberg, B.J., Wyss, P., Krasieva, T, Chandanani, N.,
McCullough, J., Berns, M.W. and Tadir, Y. (1995) Rat reproductive
performance following photodynamic therapy with topically administered
Photofrin. Hum. Reprod., 10, 227-233.
Svaasand, L.O. (1984) Optical dosimetry for direct and interstitial
photoradiation therapy of malignant tumors. In Doiron, D. and Gomer, C.J.
(eds), Porphyrin Localization and Treatment of Tumors. Alan R.Liss, New
York, NY, USA, pp. 91-114.
Tromberg, B.J., Svaasand, L.O., Fehr, M.K., Madsen, S.J., Wyss, P., Sansone,
B. and Tadir, Y. (1995) A mathematical model for light dosimetry in
photodynamic destruction of human endometrium. Phys. Med. Biol, in press.
Wyss, P., Tadir, Y, Tromberg, B.J., Liaw, L., Krasieva, T. and Berns,
M.W. (1994a) Benzoporphyrin derivative: a potent photosensitizer for
photodynamic destruction of rabbit endometrium. Obstet. Gynecoi., 84,
409-414.
Wyss, P., Tromberg, B.J., Wyss, M.T., Krasieva, T, Schell, M., Berns, M.W.
and Tadir, Y. (1994b) Photodynamic destruction of endometrial tissue with
topical 5-aminolevulinic acid in rats and rabbits. Am. J. Obstet. Gynecoi.,
171, 1176-1183.
Wyss, P., Svaasand, L.O., Tadir, Y, Haller, U., Berns, M.W., Wyss, M.T. and
Tromberg, B.J. (1995) Photomedicine of the endometrium: experimental
concepts. Hum. Reprod., 10, 221-226.
Yang, J.Z., Van Vugt, D.A., Kennedy, J.C. and Reid, R.L. (1993) Evidence
of lasting functional destruction of the rat endometrium after 5-
aminolevulinic acid-induced photodynamic ablation: prevention of
implantation. Am. J. Obstet. Gynecoi., 168, 995-1001.
Received on January 31, 1995; accepted on July 14. 1995
3072
